Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/26 18:30 | 1/20/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | D | 2 | S.d | -2,638 | 79.79 | 0 | -33 | -100 | 0 | D | |||||||||||||||
12/31/25 17:23 | 12/31/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | 2 | S.d | -11,259 | 86.61 | 0 | -130 | 663 | D | |||||||||||||||
12/12/25 18:37 | 12/10/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | 1 | S.m | -21,699 | 91.72 | 0 | -237 | 685 | I | ||||||||||||||||
12/8/25 18:09 | 12/8/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Albers Jeffrey W. | MA | D | 1 | S.d | -449 | 89.76 | 0 | -5 | -100 | 0 | D | |||||||||||||||
12/8/25 18:09 | 12/8/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Gollob Jared | MA | O | Chief Me | 1 | S.d | -4,372 | 88.67 | 0 | -49 | 110 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |